Your browser doesn't support javascript.
loading
Characterization of the Impact of Daclizumab Beta on Circulating Natural Killer Cells by Mass Cytometry.
Ranganath, Thanmayi; Simpson, Laura J; Ferreira, Anne-Maud; Seiler, Christof; Vendrame, Elena; Zhao, Nancy; Fontenot, Jason D; Holmes, Susan; Blish, Catherine A.
Affiliation
  • Ranganath T; Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States.
  • Simpson LJ; Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States.
  • Ferreira AM; Department of Statistics, Stanford University, Stanford, CA, United States.
  • Seiler C; Department of Statistics, Stanford University, Stanford, CA, United States.
  • Vendrame E; Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States.
  • Zhao N; Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States.
  • Fontenot JD; Biogen, Cambridge, MA, United States.
  • Holmes S; Department of Statistics, Stanford University, Stanford, CA, United States.
  • Blish CA; Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States.
Front Immunol ; 11: 714, 2020.
Article in En | MEDLINE | ID: mdl-32391016
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mass Spectrometry / Killer Cells, Natural / Daclizumab / Immunosuppressive Agents / Multiple Sclerosis Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Front Immunol Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mass Spectrometry / Killer Cells, Natural / Daclizumab / Immunosuppressive Agents / Multiple Sclerosis Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Front Immunol Year: 2020 Document type: Article Affiliation country: Country of publication: